Low OMega 3
Showing 1 - 25 of >10,000
LDL Hyperlipoproteinemia, Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia, Triglyceride Storage Type I or II Disease
Not yet recruiting
- LDL Hyperlipoproteinemia
- +2 more
- omega-3 fatty acids
- Placebo
-
Novosibirsk, Novosibisk Region, Russian FederationCenter of New Medical Technologies
Nov 30, 2023
Alzheimer Trial in Toulouse (Omega-3 treatment, Placebo)
Recruiting
- Alzheimer Disease
- Omega-3 treatment
- Placebo
-
Toulouse, FranceUniversity Hospital Toulouse
Aug 23, 2022
Very Low Birth Weight Infant, Bronchopulmonary Dysplasia Trial in Calgary (n3-LCPUFA enriched Intravenous Lipid Emulsion)
Recruiting
- Very Low Birth Weight Infant
- Bronchopulmonary Dysplasia
- n3-LCPUFA enriched Intravenous Lipid Emulsion
-
Calgary, Alberta, CanadaFoothills Medical Centre
Nov 4, 2022
Aggressive Periodontitis Trial in Sao Jose dos Campos (dietary supplement, drug, other, procedure)
Completed
- Aggressive Periodontitis
- Omega-3 polyunsaturated fatty acids
- +3 more
-
Sao Jose dos Campos, SP, BrazilCollege of Dentistry - São José dos Campos, Sao Paulo State Univ
Dec 23, 2021
Retinopathy of Prematurity Trial in La Jolla (Omegaven, Standard lipids (primarily omega-6 fatty acids))
Completed
- Retinopathy of Prematurity
- Omegaven
- Standard lipids (primarily omega-6 fatty acids)
-
La Jolla, CaliforniaUniversity of California, San Diego Jacobs Medical Center
Dec 13, 2021
Depression Trial in Guangzhou (omega-3, )
Enrolling by invitation
- Depression
- omega-3
- placebo
-
Guangzhou, Guangdong, ChinaNanfang Hospital
Jul 11, 2023
Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Los Angeles (behavioral, dietary
Active, not recruiting
- Adenocarcinoma of the Prostate
- +3 more
- behavioral dietary intervention
- +2 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Apr 4, 2022
Severe Acute Respiratory Syndrome-related Coronavirus, Renal Dialysis, Vaccines Trial in Chongqing (drug, diagnostic test,
Completed
- Severe Acute Respiratory Syndrome-related Coronavirus
- +4 more
- Nifedipine 30 MG
- +10 more
-
Chongqing, Chongqing, ChinaResidential Address
Feb 1, 2023
Coronary Artery Disease Trial in Ankara (Omega-3 fatty acid supplementation)
Completed
- Coronary Artery Disease
- Omega-3 fatty acid supplementation
-
Ankara, TurkeyGazi University Training and Research Hospital
Dec 14, 2022
Dry Eye Syndromes, Age-Related Macular Degeneration, Omega 3 Index Trial in Pomona (OmegaBoost, Nature Made (soft gel), Nature
Active, not recruiting
- Dry Eye Syndromes
- +2 more
- OmegaBoost
- +2 more
-
Pomona, CaliforniaWestern University of Health Sciences
Mar 8, 2023
Cardiovascular Risk Trial in Petaling Jaya (Plant Omega, Dietary therapy only)
Not yet recruiting
- Cardiovascular Risk
- Plant Omega
- Dietary therapy only
-
Petaling Jaya, Selangor, MalaysiaBeacon Hospital Sdn Bhd
May 21, 2023
Inflammation Trial in Örebro (Probiotic, Omega-3, Vitamin D supplement, Placebo)
Completed
- Inflammation
- Probiotic, Omega-3, Vitamin D supplement
- Placebo
-
Örebro, SwedenÖrebo University
Feb 23, 2021
Hypertriglyceridemia Trial in Tehran (Control, Omega-3 supplementation, Chia seed)
Not yet recruiting
- Hypertriglyceridemia
- Control
- +2 more
-
Tehran, Iran, Islamic Republic ofClinical Nutrition Research Unit, National Nutrition and Food Te
Sep 3, 2023
Type 2 Diabetes, Lipid Metabolism Disorder, Fatty Acid Metabolism Disorder Trial in Lianshui (omega-3 polyunsaturated fatty
Completed
- Type 2 Diabetes Mellitus
- +2 more
- omega-3 polyunsaturated fatty acids
- corn oil
-
Lianshui, Jiangsu, ChinaLian Shui People's Hospital
Oct 2, 2023
Autism Spectrum Disorder Trial in Dhaka (Omega 3 fatty acid, Placebo of Omega-3 fatty acid softgel capsule)
Recruiting
- Autism Spectrum Disorder
- Omega 3 fatty acid
- Placebo of Omega-3 fatty acid softgel capsule
-
Dhaka, BangladeshBSMMU
Nov 5, 2023
Absorption, Pharmacokinetics Trial in Esslingen (PL+ omega 3 fatty acids, FO EE fatty acids)
Active, not recruiting
- Absorption
- Pharmacokinetics
- PL+ omega 3 fatty acids
- FO EE fatty acids
-
Esslingen, GermanyBioTeSys GmbH
Jan 31, 2023
Concussion, Mild Trial in Winnipeg (Omega-3, Placebo)
Not yet recruiting
- Concussion, Mild
- Omega-3
- Placebo
-
Winnipeg, Manitoba, CanadaApplied Research Centre, Faculty of Kinesiology, University of M
Apr 27, 2023
Healthy Trial in Philadelphia (Fish Oil, Safflower Oil, Ethanol)
Active, not recruiting
- Healthy
- Fish Oil
- +4 more
-
Philadelphia, PennsylvaniaInstitute for Translational Medicine and Therapeutics (ITMAT), U
Dec 22, 2022
Alcohol Use Disorder, Severe Trial (Active Comparator: Omega-3, Placebo Comparator: olive oil)
Not yet recruiting
- Alcohol Use Disorder, Severe
- Active Comparator: Omega-3
- Placebo Comparator: olive oil
- (no location specified)
Jun 1, 2023
Strength, Body Composition, Muscle Soreness Trial in Waco (Omega-3 fatty acid, Placebo)
Completed
- Strength
- +2 more
- Omega-3 fatty acid
- Placebo
-
Waco, TexasBaylor University
Jun 20, 2023
Dry Eye Syndromes, Celiac Disease Trial in Tuzla (Omega-3 Fatty ACids, Control)
Recruiting
- Dry Eye Syndromes
- Celiac Disease
- Omega-3 Fatty ACids
- Control
-
Tuzla, Bosnia and HerzegovinaPlava Medical Group
Apr 11, 2023
Sarcopenia Trial (Placebo Group, Whey Protein + Placebo, Omega 3 + Placebo)
Not yet recruiting
- Sarcopenia
- Placebo Group
- +3 more
- (no location specified)
May 8, 2023
Breast Cancer Trial in Duarte, Columbus (omega 3 fatty acids)
Active, not recruiting
- Breast Cancer
- omega 3 fatty acids
-
Duarte, California
- +1 more
Jun 8, 2022
Obesity Trial in Potchefstroom (Omega-3 long chain polyunsaturated fatty acids (n-3 LCPUFA))
Recruiting
- Obesity
- Omega-3 long chain polyunsaturated fatty acids (n-3 LCPUFA)
-
Potchefstroom, South AfricaCentre of Excellence for Nutrition, North-West University
Oct 25, 2022
Skeletal Muscle Fatty Acid Metabolism Trial in Kingston (Fish oil)
Not yet recruiting
- Skeletal Muscle Fatty Acid Metabolism
- Fish oil
-
Kingston, Ontario, CanadaSchool of Kinesiology and Health Studies
Aug 1, 2023